FDA Approves 'Superiority' Labeling for new Spinal Cord Stimulator

Federal regulators have approved a new kind of spinal cord stimulator and granted the manufacturer permission to claim that its product is better than other similar devices. The U.S. Food and Drug Administration last week approved Senza, a new high-frequency spinal cord stimulator developed by the California-based Nevro for treating chronic pain in the back and legs, including failed back surgery syndrome, according to a statement from the company. The FDA approval came with “superiority” labeling, meaning that Nevro is allowed to advertise the product as working better than o...